Cassava Sciences, Inc.
6Patents
6Active
6Granted
48Portfolio score
Filing activity: Sep 26, 2016 → Nov 21, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10760052B2 | Method of inhibiting tau phosphorylation | Physics | 2 | Active |
| US12065440B2 | Solid polymorphs of a FLNA-binding compound and its hydrochloride salts | Chemistry; Metallurgy | 1 | Active |
| US11370791B2 | Solid polymorphs of a FLNA-binding compound and its hydrochloride salts | Chemistry; Metallurgy | 1 | Active |
| US11661580B2 | Method of inhibiting tau phosphorylation | Physics | 0 | Active |
| US12391693B2 | Solid polymorphs of a FLNA-binding compound and its hydrochloride salts | Chemistry; Metallurgy | 0 | Active |
| US11096936B2 | Cocrystals of naloxone and naltrexone | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.